Ā | Nā=ā17 |
---|---|
Age(years) | 58.0āĀ±ā11.3 |
Sex ratio (M: F) | 12 : 5 |
Smoke (n [%]) | 4(23) |
Alcohol abuse (n [%]) | 5(29) |
Family history of tumors (n [%]) | 3(17) |
BMI (kg/m2) | 23.8āĀ±ā2.3 |
Cholangitis manifestations (n [%]) āAbdominal pain āJaundice āFever | 8(47) 7(41) 2(12) |
Choledocholithiasis (n [%]) | 6(35) |
Laboratory tests Total bilirubin (Āµmol/L) Direct Bilirubin (Āµmol/L) Alkaline phosphatase (U/L) Ī³-glutamyl transpeptidase(U/L) CA19-9 (Āµ/ml) | 16.7(8.9,113.5) 3.8(2.7,100.9) 134.4(69.5,300.3) 103.4(28.1,294.1) 12.1(7.6,83.8) |
Dilation of the bile ducts (n [%]) | 15(88) |
Surgical approach (n [%]) Radical pancreaticoduodenectomy Radical resection for hilar cholangiocarcinoma | 16(94) 1(6) |
AH involvement sites (n [%]) Common bile duct āProximal āDistal āAmpulla of Vater Both CBD and AoV | 8(47) 1(6) 7(41) 8(47) 1(6) |
Cancer (n [%]) | 3(18) |
Mucosal glandular dysplasia (n [%]) | 8(47) |